Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Otulfi 130 mg concentrate for solution for infusion {equilateral_black_triangle}

Active Ingredient:
ustekinumab
Company:  
Fresenius Kabi Ltd See contact details
ATC code: 
L04AC05
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Patient Leaflet (PIL)
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 28 Mar 2025

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

{pdf} View or print the patient leaflet as PDF
Fresenius Kabi Ltd
Company image
Address
Cestrian Court, Eastgate Way, Manor Park, Runcorn, Cheshire, WA7 1NT
Telephone
+44 (0)1928 533 533
Fax
+44 (0)1928 533 420
Medical Information Direct Line
+44 (0)1928 533 575
Medical Information e-mail
[email protected]
Stock Availability
[email protected]
Customer Care direct line
+44 (0)1928 533 533
Medical Information Fax
+44 (0)1928 533 587
WWW
https://www.fresenius-kabi.com/gb/